Jane J. Zara

Array ( [id] => 20810315 [patent_doc_number] => 20260185136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-07-02 [patent_title] => 5'-CAP MODIFICATIONS OF RNA [patent_app_type] => utility [patent_app_number] => 19/432726 [patent_app_country] => US [patent_app_date] => 2025-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62270 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 353 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19432726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20817614 [patent_doc_number] => 12673068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-07 [patent_title] => Biologic agents and methods of use [patent_app_type] => utility [patent_app_number] => 19/353536 [patent_app_country] => US [patent_app_date] => 2025-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37403 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19353536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20535984 [patent_doc_number] => 12553050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Compositions and methods for inhibiting cytochrome P450 family 7 subfamily a member 1 (CYP7A1) expression [patent_app_type] => utility [patent_app_number] => 19/086228 [patent_app_country] => US [patent_app_date] => 2025-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 74607 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19086228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20218626 [patent_doc_number] => 20250281557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY [patent_app_type] => utility [patent_app_number] => 19/074698 [patent_app_country] => US [patent_app_date] => 2025-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19074698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20218626 [patent_doc_number] => 20250281557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY [patent_app_type] => utility [patent_app_number] => 19/074698 [patent_app_country] => US [patent_app_date] => 2025-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19074698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20033629 [patent_doc_number] => 20250171851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => BIOMARKER miR-32533 FOR COGNITIVE IMPAIRMENT-RELATED DISEASE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/051528 [patent_app_country] => US [patent_app_date] => 2025-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19051528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20534449 [patent_doc_number] => 12551500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => C6'-substituted locked nucleic acid-modified cap analog and use thereof [patent_app_type] => utility [patent_app_number] => 19/008720 [patent_app_country] => US [patent_app_date] => 2025-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 16087 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19008720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20548736 [patent_doc_number] => 12559515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-24 [patent_title] => Cap compounds and RNAS comprising the same [patent_app_type] => utility [patent_app_number] => 18/990530 [patent_app_country] => US [patent_app_date] => 2024-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11664 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18990530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20272230 [patent_doc_number] => 12442000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms [patent_app_type] => utility [patent_app_number] => 18/970086 [patent_app_country] => US [patent_app_date] => 2024-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17586 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830880 [patent_doc_number] => 20250082666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => DRUGS FOR PREVENTION OR TREATMENT OF SEPSIS [patent_app_type] => utility [patent_app_number] => 18/955967 [patent_app_country] => US [patent_app_date] => 2024-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18955967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19910426 [patent_doc_number] => 12286627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-29 [patent_title] => Method for preventing dsRNA bacterial solutions from being degraded by UV light and application thereof in control of silverleaf whiteflies [patent_app_type] => utility [patent_app_number] => 18/930307 [patent_app_country] => US [patent_app_date] => 2024-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 4038 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19770348 [patent_doc_number] => 20250051774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => DIRECT PRODUCTION OF SIRNAS IN SACCHAROMYCES BOULARDII AND PACKAGING IN EXTRACELLULAR VESICLES (EVs) FOR TARGETED GENE SILENCING [patent_app_type] => utility [patent_app_number] => 18/895210 [patent_app_country] => US [patent_app_date] => 2024-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18895210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20227389 [patent_doc_number] => 12416032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-16 [patent_title] => Synthetic self-amplifying MRNA molecules with secretion antigen and immunomodulator [patent_app_type] => utility [patent_app_number] => 18/801051 [patent_app_country] => US [patent_app_date] => 2024-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 31 [patent_no_of_words] => 34104 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18801051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20116209 [patent_doc_number] => 12365901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Application of mechanical-force sensitive macrophage subset in pancreatic cancer diagnosis or prognosis evaluation [patent_app_type] => utility [patent_app_number] => 18/793716 [patent_app_country] => US [patent_app_date] => 2024-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 3366 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18793716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20264372 [patent_doc_number] => 12435350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Complex for synthesizing nucleotide strand and method for synthesizing nucleotide strand [patent_app_type] => utility [patent_app_number] => 18/786649 [patent_app_country] => US [patent_app_date] => 2024-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11815 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18786649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19800854 [patent_doc_number] => 20250066779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => ADVANCED RNA TARGETING (ARNATAR) FOR ANGIOTENSINOGEN [patent_app_type] => utility [patent_app_number] => 18/751048 [patent_app_country] => US [patent_app_date] => 2024-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18751048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20592405 [patent_doc_number] => 12576101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Application based nucleotides of [patent_app_type] => utility [patent_app_number] => 18/677546 [patent_app_country] => US [patent_app_date] => 2024-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 0 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18677546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20414343 [patent_doc_number] => 12497616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Compounds targeting PMP22 for the treatment of Charcot-Marie-Tooth disease [patent_app_type] => utility [patent_app_number] => 18/660600 [patent_app_country] => US [patent_app_date] => 2024-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 101215 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19624364 [patent_doc_number] => 12163172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Reagents and methods used in deprotection of 3'-O-amino polynucleotides [patent_app_type] => utility [patent_app_number] => 18/654906 [patent_app_country] => US [patent_app_date] => 2024-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 10630 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19519879 [patent_doc_number] => 12121577 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-10-22 [patent_title] => mRNA treatment nanoparticles [patent_app_type] => utility [patent_app_number] => 18/606473 [patent_app_country] => US [patent_app_date] => 2024-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 70 [patent_no_of_words] => 43267 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606473 [rel_patent_id] =>[rel_patent_doc_number] =>)